Nevro is not issuing FY25 guidance
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 04 2025
0mins
- Acquisition Impact: Nevro will not provide FY25 guidance or hold an earnings call due to its pending acquisition by Globus Medical.
- Financial Reporting: The company is reporting its Q4 and FY24 financial results without the usual conference call and webcast.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
